HIV Treatment with the Two-Drug Regimen Dolutegravir Plus Lamivudine in Real-world Clinical Practice: A Systematic Literature Review.

Autor: Patel R; ViiV Healthcare, 980 Great West Road, Brentford, TW8 9GS, Middlesex, UK. rickesh.x.patel@viivhealthcare.com., Evitt L; ViiV Healthcare, 980 Great West Road, Brentford, TW8 9GS, Middlesex, UK., Mariolis I; ViiV Healthcare, Athens, Greece., Di Giambenedetto S; UOC Malattie Infettive, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.; Dipartimento di Sicurezza e Bioetica, Sezione di Malattie Infettive, Università Cattolica del Sacro Cuore, Rome, Italy., d'Arminio Monforte A; Department of Health Sciences, Clinic of Infectious Diseases, 'San Paolo' Hospital, University of Milan, Milan, Italy., Casado J; Hospital Universitario Ramón y Cajal, Madrid, Spain., Cabello Úbeda A; Infectious Diseases Division, Fundación Jimenez Diaz University Hospital, Madrid, Spain., Hocqueloux L; Infectious Diseases Department, Centre Hospitalier Régional d'Orléans, Orléans, France., Allavena C; Infectious Diseases Department, CHU Hôtel-Dieu, Nantes, France., Barber T; Royal Free London NHS Foundation Trust, London, UK., Jha D; GlaxoSmithKline Knowledge Centre, Gurgaon, Haryana, India., Kumar R; GlaxoSmithKline Knowledge Centre, Gurgaon, Haryana, India., Kamath RD; GlaxoSmithKline Knowledge Centre, Gurgaon, Haryana, India., Vincent T; ViiV Healthcare, 980 Great West Road, Brentford, TW8 9GS, Middlesex, UK., van Wyk J; ViiV Healthcare, 980 Great West Road, Brentford, TW8 9GS, Middlesex, UK., Koteff J; ViiV Healthcare, Research Triangle Park, NC, USA.

Publikováno v: Infectious diseases and therapy [Infect Dis Ther] 2021 Dec; Vol. 10 (4), pp. 2051-2070. Date of Electronic Publication: 2021 Aug 24.